Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

AB Foods to 'tread water' but long-term optimism remains, says Shore Capital

(Sharecast News) - Shares in Associated British Foods tanked on Wednesday after the retail and foods conglomerate reported a mixed trading update - something which may cause the stock to "tread water for a while", according to Shore Capital. The broker, which retained a 'buy' stance on the shares despite the market's negative reaction, said that while this year has created "notable bumps in the road", the long-term investment view for ABF still remains positive and "a smoother surface should benefit shareholders in FY26 and thereafter".

Nevertheless, the stock dropped 10% after the company reported a weaker performance in its sugar division and muted growth at Primark, as well as a £200m impairment charge to close its Vivergo bioethanol plant and restructure its Spanish sugar business.

Shore Capital said that results for the year to 13 September are likely to be weaker than anticipated, and forecasts will have to be "nudged down".

"On c11-12x FY26F PER, we still feel that there is much to like about ABF's equity - values, relevance, balance sheet and opportunities - but for shareholders to be rewarded on an ongoing basis, it needs to deliver sequential earnings progress to us," Shore Capital said.

"When the stars align across ABF's divisions, it is a most compelling entity from earnings, cash generation and returns perspectives. Alas [...] there have been some deceleration to progress in recent times, challenging the galactic alignment but not the wider long-term thesis, all predicated upon a strong balance sheet in our view."

By 1009 BST, the stock was down 10.4% at 2,007p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.